Single-centre, randomised, double-blind, split-face comparative design clinical trial to evaluate the efficacy and safety of the topical formulation with 4% hydroquinone and 0,025% tretinoin versus the formulation with 4% hydroquinone in patients with facial melasma
This research study is investigating new ways to treat facial melasma, a common skin condition that causes dark, discoloured patches to appear on the face. The study aims to find out if a cream containing two medicines, 4% hydroquinone and 0.025% tretinoin, is more effective and safer than a cream containing only 4% hydroquinone. Both creams are applied to the skin. During the study, both creams will be used on different parts of a patient's face, allowing doctors to directly compare their effects. This is a very early-stage study, meaning it's one of the first times these specific cream combinations are being tested in people. The goal is to help improve treatments for women aged 18 and over who live with facial melasma.
At a glance
What is this study about?
Melasma is a skin condition that causes brown or grey-brown patches to appear, usually on the face. It's often linked to sun exposure, hormonal changes (like pregnancy or birth control), and genetics. While it's not harmful, it can sometimes affect how people feel about their appearance. This study is trying to find better ways to treat these patches and make them less noticeable.
Researchers are comparing two different creams. Both creams contain a medicine called hydroquinone, which helps to lighten dark skin patches. One of the creams also contains another medicine called tretinoin, which can help skin cells turn over more quickly and improve the look of skin.
By comparing these two creams directly on the same person's face, the researchers hope to understand which combination of medicines works best to reduce melasma, how safe they are to use, and if they cause any side effects. This kind of research is important because it helps doctors develop more effective and safer treatments for conditions like melasma in the future.
Key takeaways
- This study is testing two different creams for facial melasma.
- It aims to find out which cream is more effective and safer.
- Study participants will apply different creams to different sides of their face.
- It's an early-stage study, focusing on women aged 18 and over.
- Regular clinic visits will monitor progress and check for side effects.
Who may be eligible?
To take part in this study, you need to be a woman who is at least 18 years old. There's no upper age limit, meaning older women can also participate. The main requirement is that you have facial melasma, which means you have the dark patches on your face that the study is trying to treat.
Because this study is comparing two different creams on your face, it's likely that the researchers will need to check your skin closely to make sure you're a good fit. They'll want to ensure your melasma is suitable for this type of comparison.
It’s important to talk to your doctor or the study team to see if you meet all the specific requirements, as there might be other medical conditions or medications that could prevent you from joining.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you a woman?
- Are you 18 years old or older?
- Do you have melasma on your face?
- Are you able to attend regular clinic visits?
What does participation involve?
If you decide to take part, you'll be given two different creams to apply to specific areas of your face – one cream on one side and the other cream on the other side. You won't know which cream is which, and neither will the study team, to ensure the results are fair. You'll need to apply these creams as directed by the study team, typically every day for a set period.
You'll have several visits to the clinic where doctors and nurses will check your skin closely, take photos, and ask about how you're feeling and any side effects you might be having. These checks help them see how well the creams are working and if they are safe. You'll continue to be monitored throughout the study period. The exact number of visits and the total length of time you'll be involved will be explained by the study team, but it will likely involve regular check-ups over several weeks or months. You’ll be given all the medication you need for the study.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
What is melasma?
Melasma is a common skin condition that causes dark, discoloured patches to appear, usually on your face.
What are hydroquinone and tretinoin?
They are medicines often used in skin creams. Hydroquinone helps lighten dark spots, and tretinoin helps your skin renew itself.
How long will the study last?
The study team will tell you the exact duration, but it typically involves several weeks or months of treatment and follow-up visits.
Will I know which cream I'm using?
No, this is a 'blinded' study, meaning you won't know which cream is on which side of your face. This helps keep results fair.
Can I leave the study if I change my mind?
Yes, you are free to withdraw from the study at any time without having to give a reason, and it won't affect your medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.